CIA
BRLI

Capital Impact Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Capital Impact Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-22,377
Closed -$923K – 266
2015
Q2 		$923K Hold
22,377
– – 0.42% 82
2015
Q1 		$789K Buy
22,377
+16,979
+315% +$574K 0.36% 109
2014
Q4 		$173K Hold
5,398
– – 0.08% 142
2014
Q3 		$151 Sell
5,398
-17,344
-76% -$528K ﹤0.01% 139
2014
Q2 		$687K Sell
22,742
-36,451
-62% -$1.01M 0.52% 75
2014
Q1 		$1.64M Hold
59,193
– – 1.32% 23
2013
Q4 		$1.51M Buy
+59,193
New +$1.82M 1.21% 36

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Capital Impact Advisors's BRLI Position: Q3 2015 in Review

Capital Impact Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 22,377 shares — an estimated $923K sold.

Capital Impact Advisors first reported a position in BRLI in Q4 2013 and held it in 7 quarters. The position peaked at $1.64M in Q1 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Capital Impact Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Capital Impact Advisors sold 22,377 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $923K.
  • Capital Impact Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 7 quarters.
  • Capital Impact Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $1.64M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Capital Impact Advisors's 13F filing for Q3 2015, filed 7 Oct 2015.